Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Chief Counsel Is Assistant Attorney General Bradshaw

This article was originally published in The Pink Sheet Daily

Executive Summary

Bradshaw brings extensive high-level government service experience to the position as he permanently replaces former Chief Counsel Troy. Deputy Chief Counsel Masoudi has served in the position on an interim basis since Troy’s departure in November.
Advertisement

Related Content

FDA Chief Counsel Says Generic Firms Make Strong Case For Preemption
FDA Chief Counsel Says Generic Firms Make Strong Case For Preemption
FDA Chief Counsel Bradshaw's "Practical" Approach Applauded By Barr
FDA Chief Counsel Bradshaw's "Practical" Approach Applauded By Barr
FDA Acting Chief Counsel To Be Masoudi
FDA Acting Chief Counsel To Be Masoudi
Deputy Chief Counsel Masoudi Brings Antitrust Law Background To FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS062126

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel